BamSEC and AlphaSense Join Forces
Learn More

Viracta Therapeutics Inc.

NASDAQ: VIRX    
Share price (12/23/24): $0.23    
Market cap (12/23/24): $9.248 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc. [Signature Page Follows]
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 425 1 page Amendment to the Amended and Restated Bylaws of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Amended and Restated Bylaws of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 17 pages Sunesis Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series F Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series F Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 17 pages Sunesis Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series E Convertible Preferred Stock
12/34/56
EX-3.11
from 10-Q 6 pages Of Certificate of Amendment to Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 16 pages Sunesis Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series D Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 16 pages Sunesis Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series C Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 16 pages Sunesis Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series B Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.5
from 8-K 2 pages Certificate of Amendment of the Certificate of Designation of the Series a Preferred Stock of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.4
from 8-K 2 pages Certificate of Amendment of the Certificate of Designation of the Series a Preferred Stock of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.4
from S-8 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.3
from 8-K 10 pages Certificate of Designation of the Series a Preferred Stock of Sunesis Pharmaceuticals, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 19 pages Amended and Restated Bylaws of Sunesis Pharmaceuticals, Inc. (A Delaware Corporation) (Approved December 5, 2007) I
12/34/56
EX-3.2
from 10-K/A 20 pages Amended and Restated Bylaws of Sunesis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-K/A 5 pages Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc
12/34/56